Joshua D. Rovin

Joshua D. Rovin

Thoracic Surgery | General Surgery

455 Pinellas St
Ste 320
Clearwater, FL 33756

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Core-Laboratory Evaluation of Implantation Depth and Clinical Outcomes in TAVR: Optimize PRO Study.

Core-Laboratory Evaluation of Implantation Depth and Clinical Outcomes in TAVR: Optimize PRO Study.

Journal: JACC. Cardiovascular interventions

Published: April 27, 2026

Impact of TAVR Failure Mechanism on Outcomes After Reintervention: From the EXPLANTORREDO-TAVR Registry.

Impact of TAVR Failure Mechanism on Outcomes After Reintervention: From the EXPLANTORREDO-TAVR Registry.

Journal: Circulation. Cardiovascular interventions

Published: April 15, 2026

Impact of TAVR Failure Mechanism on Outcomes After Reintervention: From the EXPLANTORREDO-TAVR Registry.

Impact of TAVR Failure Mechanism on Outcomes After Reintervention: From the EXPLANTORREDO-TAVR Registry.

Journal: Circulation. Cardiovascular interventions

Published: April 15, 2026

10-Year Outcomes of SAPIEN 3 Transcatheter Aortic Valve Replacement or Surgery in Intermediate-Risk Patients.

10-Year Outcomes of SAPIEN 3 Transcatheter Aortic Valve Replacement or Surgery in Intermediate-Risk Patients.

Journal: Journal of the American College of Cardiology

Published: January 02, 2026

Transcatheter aortic valve implantation with the Trilogy valve for symptomatic native aortic regurgitation (ALIGN-AR): a pivotal, multicentre, single-arm, investigational device exemption study.

Transcatheter aortic valve implantation with the Trilogy valve for symptomatic native aortic regurgitation (ALIGN-AR): a pivotal, multicentre, single-arm, investigational device exemption study.

Journal: Lancet (London, England)

Published: September 30, 2025

30-Day and 1-Year Outcomes From the Optimize PRO TAVR Evolut FX Addendum Study.

30-Day and 1-Year Outcomes From the Optimize PRO TAVR Evolut FX Addendum Study.

Journal: JACC. Cardiovascular interventions

Published: May 16, 2025

Global Results From the Optimize PRO Study: Standardized TAVR Technique and Care Pathway.

Global Results From the Optimize PRO Study: Standardized TAVR Technique and Care Pathway.

Journal: Journal of the Society for Cardiovascular Angiography & Interventions

Published: December 10, 2024

Transcatheter Aortic Valve Implantation by Valve Type in Women With Small Annuli: Results From the SMART Randomized Clinical Trial.

Transcatheter Aortic Valve Implantation by Valve Type in Women With Small Annuli: Results From the SMART Randomized Clinical Trial.

Journal: JAMA cardiology

Published: October 09, 2024

Impact of Transcatheter or Surgical Aortic Valve Performance on 5-Year Outcomes in Patients at ≥ Intermediate Risk.

Impact of Transcatheter or Surgical Aortic Valve Performance on 5-Year Outcomes in Patients at ≥ Intermediate Risk.

Journal: Journal of the American College of Cardiology

Published: July 24, 2024

Four-year outcomes after transcatheter or contemporary surgical aortic valve replacement from the Evolut Low Risk trial.

Four-year outcomes after transcatheter or contemporary surgical aortic valve replacement from the Evolut Low Risk trial.

Journal: The Journal of thoracic and cardiovascular surgery

Published: June 24, 2024

Self-Expanding or Balloon-Expandable TAVR in Patients with a Small Aortic Annulus.

Self-Expanding or Balloon-Expandable TAVR in Patients with a Small Aortic Annulus.

Journal: The New England journal of medicine

Published: April 08, 2024

3-Year Outcomes From the Evolut Low Risk TAVR Bicuspid Study.

3-Year Outcomes From the Evolut Low Risk TAVR Bicuspid Study.

Journal: JACC. Cardiovascular interventions

Published: March 01, 2024

Showing 1-12 of 31

Last Updated: 09/26/2026